Navigation Links
Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Date:7/1/2008

e at 15 minute intervals for 24 hours with the study data blinded to study subjects and study personnel.

About Echo Therapeutics

Echo Therapeutics is focused on medical devices and specialty pharmaceuticals. Echo is developing a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system for patients with diabetes and for use in hospital critical care units, together with a wide range of novel topical reformulations of widely-used, FDA-approved products.

Cautionary Statement Regarding Forward Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward- looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies regarding the efficacy of Echo's Symphony tCGM System, the failure of future development and preliminary marketing efforts related to Echo's tCGM systems, risks and uncertainties relating to Echo's ability to develop, market and sell diagnostic products based on its skin permeation platform technologies, including the Prelude SkinPrep System, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, and regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its tCGM systems. Furthermore, Echo's tCGM system has not yet been approved for sale. The regulatory approval process for its tCGM system involves, among other factors, successfully completing pilot and pivotal clinica
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Silence Therapeutics Announces Board Changes
2. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
3. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
4. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
5. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
6. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
7. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... PITTSBURGH , July 30, 2014   ... Markets Groups Inc.: OTC Pink: UPZS), a Delaware ... a distribution agreement with Larasan Pharmaceutical Corporation ("Larasan"), a ... products.  According to the agreement, US-based Larasan will ... gourmet 6" frozen pizza through Larasan,s vast distribution ...
(Date:7/30/2014)... KISSING, Germany , July 30, 2014 ... single use and computer-assisted ("robotic") colonoscopy system, today announced ... worldwide recognized medical device executive, as a new member ... is a highly respected global visionary in the medical ... as President and Chief Executive Officer at Given Imaging ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
Breaking Medicine Technology:Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... 2011 Thoratec Corporation (NASDAQ: THOR ... support therapies to save, support and restore failing ... WiTricity Corporation relating to WiTricity,s proprietary wireless resonant ... of mechanical circulatory support. Through a ...
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today ... 2011, and reviewed recent developments. "In collaboration ... support the submission of our response to the FDA,s complete ... Lief, Arena,s President and Chief Executive Officer. "We are also ...
Cached Medicine Technology:Thoratec Announces Development Agreement With WiTricity for Proprietary Energy Transfer Technology 2Thoratec Announces Development Agreement With WiTricity for Proprietary Energy Transfer Technology 3Thoratec Announces Development Agreement With WiTricity for Proprietary Energy Transfer Technology 4Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments 8
(Date:7/30/2014)... ... ... ... , UCLA researchers interviewed ... study, published this week in the peer-reviewed journal Quality of Life Research , a UCLA team led by Dr. Brennan Spiegel ...
(Date:7/30/2014)... 2014 The Ehlers-Danlos National Foundation (EDNF) ... Sandra Aiken Chack will serve as chair. The board ... 2014 Annual Learning Conference in Houston, Texas July 10-12. ... agenda ahead of us. From the rollout of the ... the Greater Baltimore Medical Center to our September physicians ...
(Date:7/30/2014)... LTC Consumer, an independent, free online service to help consumers ... Quote tool on its website, LTCconsumer.com , announced Nathan ... free and unlimited. , The Instant Quote tool ... age, gender, and state of residence – and delivers a ... enter any contact information to get started). There is no ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 The ... to U.S. Sens. Thad Cochran (R-MS) and Roger ... improvements in telemedicine coverage under Medicare, Medicaid and ... Wicker, both Mississippi Republicans, introduced the Telehealth Enhancement ... a House version, H.R. 3306, introduced by Rep. ...
(Date:7/30/2014)... 2014 Hospitals continually face the ... care that their practitioners provide. During a recent ... discussed the importance of establishing effective peer review ... and quality of care. , With regard ... Rowe elaborated on setting performance expectations, conducting regular ...
Breaking Medicine News(10 mins):Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3Health News:Ehlers-Danlos National Foundation Announces New Leadership 2Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2Health News:ATA Applauds Senators’ Push for Federal Telemedicine Improvements 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 2Health News:AllMed Webinar Helps Hospitals Optimize Practitioner Evaluations in Peer Review 3
... , WOODLAND HILLS, Calif., Sept. 22 ... the California Governor,s Council on Physical Fitness and Sports, is ... moving and empower them to make healthy lifestyle choices now ... view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/livelikeachampion/40152/ ...
... , , RICHMOND, Va., Sept. 22 ... Richmond Health System has been named among the Top Ten 2009 ... benefits. Bon Secours Richmond has been named to Working Mother ,s ... Ten in both 2006 and 2009. , , "Being ...
... ... launch of two newly redesigned websites, R&D ( http://www.rdmag.com ) and Wireless Week ( ... to foster an online community for their users. , ... Rockaway, New Jersey (PRWEB) September 22, 2009 -- ...
... , DUQUESNE, Pa., Sept. 22 Wherever you ... the house. From pulling out blankets, replacing smoke detector batteries, varying ... "flipping" their home routines in the fall. , ... , If you are one of the estimated ...
... IBI Lost Productivity Calculators based on research with ... Sept. 22 To enable employers to estimate the productivity ... created three proprietary, on-line Lost Productivity Calculators for its members. ... company, a specific occupation group, or a specific group of ...
... Oncology (ESMO) has recognized the outstanding achievements of three ... the 2009 ESMO Award, Hamilton Fairley Award and ESMO ... Lead for Medical Oncology, Institute of Cancer, Barts and ... the 2009 Hamilton Fairley Award. The award commemorates one ...
Cached Medicine News:Health News:Video: Anthem Blue Cross and the California Governor's Council on Physical Fitness and Sports Launch the Live Like a Champion Tour 2Health News:Video: Anthem Blue Cross and the California Governor's Council on Physical Fitness and Sports Launch the Live Like a Champion Tour 3Health News:Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 2Health News:Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 3Health News:Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 4Health News:Advantage Business Media Launches Enhanced Websites 2Health News:Advantage Business Media Launches Enhanced Websites 3Health News:'Flip for Fall' Seasonal Household Tips Include Ten Million Reasons to Use Allergy-Protective Bedding 2Health News:'Flip for Fall' Seasonal Household Tips Include Ten Million Reasons to Use Allergy-Protective Bedding 3Health News:Integrated Benefits Institute Launches Productivity Modeling Tools to Help Employers Estimate the Impact of Absent Employees 2Health News:ESMO recognizes leading oncologists with prestigious awards 2Health News:ESMO recognizes leading oncologists with prestigious awards 3
... F340 is a basic laboratory system for ... results can be obtained when used with ... electrode. • Fast and easy one and ... for five buffers (pH 1.68, 4.00, 7.00, ...
... the multifunctional high-end microplate reader with outstanding ... modes., Fluorescence Intensity - FRET , ... HTRF, AlphaScreen , Luminescence , ... emission microplate reader with fastest read times. ...
... microplate reader combines improved flexibility ... with a wide range of ... the flexibility, sensitivity and high ... is the ideal detection solution ...
... for Ultra High Throughput Screening (UHTS), ... detection performance. Allows for smooth transfer ... development by sharing all the detection ... fluorescence intensity, fluorescence polarization, time-resolved fluorescence, ...
Medicine Products: